Acro Biomedical (ACBM) Receivables (2021 - 2023)

Acro Biomedical's Receivables history runs 3 years deep, the most recent figure standing at $498500.0 for Q2 2023.

• In Q2 2023, Receivables rose 67.0% year-over-year to $498500.0; the TTM figure through Jun 2023 stood at $498500.0 (up 67.0% YoY), while the FY2022 annual figure was $638500.0, up 6.77% from the prior year.
• Receivables was $498500.0 for Q2 2023 at Acro Biomedical, down from $608500.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $638500.0 in Q4 2022 to a low of $278500.0 in Q3 2022.
• Historically, Receivables has averaged $459857.1 across 3 years, with a median of $498500.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Receivables rose 6.77% in 2022, then surged 103.85% in 2023.
• A 3-year view of Receivables shows it stood at $598000.0 in 2021, then grew by 6.77% to $638500.0 in 2022, then declined by 21.93% to $498500.0 in 2023.
• The last three Receivables figures came in at $498500.0 (Q2 2023), $608500.0 (Q1 2023), and $638500.0 (Q4 2022), per Business Quant data.